The University of Chicago Header Logo

Connection

Yusuke Nakamura to Cell Line, Tumor

This is a "connection" page, showing publications Yusuke Nakamura has written about Cell Line, Tumor.
Connection Strength

4.294
  1. Enhancement of Migration and Invasion of Gastric Cancer Cells by IQGAP3. Biomolecules. 2020 08 17; 10(8).
    View in: PubMed
    Score: 0.115
  2. The GALNT6-LGALS3BP axis promotes breast cancer cell growth. Int J Oncol. 2020 Feb; 56(2):581-595.
    View in: PubMed
    Score: 0.109
  3. MELK inhibition targets cancer stem cells through downregulation of SOX2 expression in head and neck cancer cells. Oncol Rep. 2019 Apr; 41(4):2540-2548.
    View in: PubMed
    Score: 0.103
  4. Critical Role of Estrogen Receptor Alpha O-Glycosylation by N-Acetylgalactosaminyltransferase 6 (GALNT6) in Its Nuclear Localization in Breast Cancer Cells. Neoplasia. 2018 10; 20(10):1038-1044.
    View in: PubMed
    Score: 0.100
  5. Effects of SMYD2-mediated EML4-ALK methylation on the signaling pathway and growth in non-small-cell lung cancer cells. Cancer Sci. 2017 Jun; 108(6):1203-1209.
    View in: PubMed
    Score: 0.092
  6. Phosphatidylinositol glycan anchor biosynthesis, class X containing complex promotes cancer cell proliferation through suppression of EHD2 and ZIC1, putative tumor suppressors. Int J Oncol. 2016 Sep; 49(3):868-76.
    View in: PubMed
    Score: 0.086
  7. Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor. Oncotarget. 2016 Apr 05; 7(14):18171-82.
    View in: PubMed
    Score: 0.085
  8. A unique hinge binder of extremely selective aminopyridine-based Mps1 (TTK) kinase inhibitors with cellular activity. Bioorg Med Chem. 2015 May 01; 23(9):2247-60.
    View in: PubMed
    Score: 0.079
  9. TOPK inhibitor induces complete tumor regression in xenograft models of human cancer through inhibition of cytokinesis. Sci Transl Med. 2014 Oct 22; 6(259):259ra145.
    View in: PubMed
    Score: 0.077
  10. Late Cornified Envelope Group I, a novel target of p53, regulates PRMT5 activity. Neoplasia. 2014 Aug; 16(8):656-64.
    View in: PubMed
    Score: 0.075
  11. Identification of a nuclear protein, LRRC42, involved in lung carcinogenesis. Int J Oncol. 2014 Jul; 45(1):147-56.
    View in: PubMed
    Score: 0.074
  12. Downregulation of the tumor suppressor HSPB7, involved in the p53 pathway, in renal cell carcinoma by hypermethylation. Int J Oncol. 2014 May; 44(5):1490-8.
    View in: PubMed
    Score: 0.073
  13. Indazole-based potent and cell-active Mps1 kinase inhibitors: rational design from pan-kinase inhibitor anthrapyrazolone (SP600125). J Med Chem. 2013 Jun 13; 56(11):4343-56.
    View in: PubMed
    Score: 0.069
  14. MELK inhibitor, novel molecular targeted therapeutics for human cancer stem cells. Cell Cycle. 2013 Jun 01; 12(11):1655-6.
    View in: PubMed
    Score: 0.069
  15. The DNA binding site specificity and antiproliferative property of ternary Pt(II) and Zn(II) complexes of phenanthroline and N,N'-ethylenediaminediacetic acid. Dalton Trans. 2013 Mar 14; 42(10):3337-45.
    View in: PubMed
    Score: 0.068
  16. Critical function for nuclear envelope protein TMEM209 in human pulmonary carcinogenesis. Cancer Res. 2012 Aug 15; 72(16):4110-8.
    View in: PubMed
    Score: 0.065
  17. C12orf48, termed PARP-1 binding protein, enhances poly(ADP-ribose) polymerase-1 (PARP-1) activity and protects pancreatic cancer cells from DNA damage. Genes Chromosomes Cancer. 2011 Jan; 50(1):13-24.
    View in: PubMed
    Score: 0.059
  18. Critical involvement of RQCD1 in the EGFR-Akt pathway in mammary carcinogenesis. Int J Oncol. 2010 Nov; 37(5):1085-93.
    View in: PubMed
    Score: 0.058
  19. Critical roles of LGN/GPSM2 phosphorylation by PBK/TOPK in cell division of breast cancer cells. Genes Chromosomes Cancer. 2010 Oct; 49(10):861-72.
    View in: PubMed
    Score: 0.058
  20. Involvement of C12orf32 overexpression in breast carcinogenesis. Int J Oncol. 2010 Oct; 37(4):861-7.
    View in: PubMed
    Score: 0.058
  21. Involvement of RQCD1 overexpression, a novel cancer-testis antigen, in the Akt pathway in breast cancer cells. Int J Oncol. 2009 Oct; 35(4):673-81.
    View in: PubMed
    Score: 0.054
  22. Involvement of TMEM22 overexpression in the growth of renal cell carcinoma cells. Oncol Rep. 2009 Feb; 21(2):305-12.
    View in: PubMed
    Score: 0.052
  23. Genome-wide gene expression profiles of thyroid carcinoma: Identification of molecular targets for treatment of thyroid carcinoma. Oncol Rep. 2008 Jul; 20(1):105-21.
    View in: PubMed
    Score: 0.049
  24. Phosphorylation and activation of cell division cycle associated 8 by aurora kinase B plays a significant role in human lung carcinogenesis. Cancer Res. 2007 May 01; 67(9):4113-22.
    View in: PubMed
    Score: 0.046
  25. Oncogenic role of MPHOSPH1, a cancer-testis antigen specific to human bladder cancer. Cancer Res. 2007 Apr 01; 67(7):3276-85.
    View in: PubMed
    Score: 0.045
  26. Activation of CDCA1-KNTC2, members of centromere protein complex, involved in pulmonary carcinogenesis. Cancer Res. 2006 Nov 01; 66(21):10339-48.
    View in: PubMed
    Score: 0.044
  27. Therapeutic potential of antibodies against FZD 10, a cell-surface protein, for synovial sarcomas. Oncogene. 2005 Sep 15; 24(41):6201-12.
    View in: PubMed
    Score: 0.041
  28. Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer. Cancer Res. 2005 Aug 15; 65(16):7102-10.
    View in: PubMed
    Score: 0.041
  29. Identification of immunoglobulin superfamily 11 (IGSF11) as a novel target for cancer immunotherapy of gastrointestinal and hepatocellular carcinomas. Cancer Sci. 2005 Aug; 96(8):498-506.
    View in: PubMed
    Score: 0.040
  30. A novel human tRNA-dihydrouridine synthase involved in pulmonary carcinogenesis. Cancer Res. 2005 Jul 01; 65(13):5638-46.
    View in: PubMed
    Score: 0.040
  31. PCOTH, a novel gene overexpressed in prostate cancers, promotes prostate cancer cell growth through phosphorylation of oncoprotein TAF-Ibeta/SET. Cancer Res. 2005 Jun 01; 65(11):4578-86.
    View in: PubMed
    Score: 0.040
  32. Overexpressed P-cadherin/CDH3 promotes motility of pancreatic cancer cells by interacting with p120ctn and activating rho-family GTPases. Cancer Res. 2005 Apr 15; 65(8):3092-9.
    View in: PubMed
    Score: 0.040
  33. p53CSV, a novel p53-inducible gene involved in the p53-dependent cell-survival pathway. Cancer Res. 2005 Feb 15; 65(4):1197-206.
    View in: PubMed
    Score: 0.039
  34. Down-regulation of RAB6KIFL/KIF20A, a kinesin involved with membrane trafficking of discs large homologue 5, can attenuate growth of pancreatic cancer cell. Cancer Res. 2005 Jan 01; 65(1):105-12.
    View in: PubMed
    Score: 0.039
  35. ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain. Oncogene. 2004 Oct 07; 23(46):7601-10.
    View in: PubMed
    Score: 0.038
  36. Identification of STAG1 as a key mediator of a p53-dependent apoptotic pathway. Oncogene. 2004 Oct 07; 23(46):7621-7.
    View in: PubMed
    Score: 0.038
  37. Identification of RNF213 as a Potential Suppressor of Local Invasion in Intrahepatic Cholangiocarcinoma. Lab Invest. 2024 07; 104(7):102074.
    View in: PubMed
    Score: 0.037
  38. Isolation of development and differentiation enhancing factor-like 1 (DDEFL1) as a drug target for hepatocellular carcinomas. Int J Oncol. 2004 Jan; 24(1):43-8.
    View in: PubMed
    Score: 0.036
  39. Methylation at CpG islands in intron 1 of EGR2 confers enhancer-like activity. FEBS Lett. 2003 Nov 06; 554(1-2):67-72.
    View in: PubMed
    Score: 0.036
  40. Identification of COX17 as a therapeutic target for non-small cell lung cancer. Cancer Res. 2003 Nov 01; 63(21):7038-41.
    View in: PubMed
    Score: 0.036
  41. Involvement of the FGF18 gene in colorectal carcinogenesis, as a novel downstream target of the beta-catenin/T-cell factor complex. Cancer Res. 2003 Oct 01; 63(19):6116-20.
    View in: PubMed
    Score: 0.036
  42. FZD10-targeted a-radioimmunotherapy with 225 Ac-labeled OTSA101 achieves complete remission in a synovial sarcoma model. Cancer Sci. 2022 Feb; 113(2):721-732.
    View in: PubMed
    Score: 0.031
  43. High expression of maternal embryonic leucine-zipper kinase (MELK) impacts clinical outcomes in patients with ovarian cancer and its inhibition suppresses ovarian cancer cells growth ex vivo. J Gynecol Oncol. 2020 Nov; 31(6):e93.
    View in: PubMed
    Score: 0.029
  44. Established fibrous peritoneal metastasis in an immunocompetent mouse model similar to clinical immune microenvironment of gastric cancer. BMC Cancer. 2020 Oct 20; 20(1):1014.
    View in: PubMed
    Score: 0.029
  45. Potent anti-myeloma activity of the TOPK inhibitor OTS514 in pre-clinical models. Cancer Med. 2020 01; 9(1):324-334.
    View in: PubMed
    Score: 0.027
  46. Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma. Mol Cancer Ther. 2019 03; 18(3):507-516.
    View in: PubMed
    Score: 0.026
  47. The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation. PLoS One. 2018; 13(8):e0202272.
    View in: PubMed
    Score: 0.025
  48. a-particle therapy for synovial sarcoma in the mouse using an astatine-211-labeled antibody against frizzled homolog 10. Cancer Sci. 2018 Jul; 109(7):2302-2309.
    View in: PubMed
    Score: 0.025
  49. Protein lysine methyltransferase SMYD3 is involved in tumorigenesis through regulation of HER2 homodimerization. Cancer Med. 2017 Jul; 6(7):1665-1672.
    View in: PubMed
    Score: 0.023
  50. Loss of BRCA1 in the Cells of Origin of Ovarian Cancer Induces Glycolysis: A Window of Opportunity for Ovarian Cancer Chemoprevention. Cancer Prev Res (Phila). 2017 Apr; 10(4):255-266.
    View in: PubMed
    Score: 0.023
  51. GALNT6 Stabilizes GRP78 Protein by O-glycosylation and Enhances its Activity to Suppress Apoptosis Under Stress Condition. Neoplasia. 2017 01; 19(1):43-53.
    View in: PubMed
    Score: 0.022
  52. T-LAK Cell-Originated Protein Kinase (TOPK) as a Prognostic Factor and a Potential Therapeutic Target in Ovarian Cancer. Clin Cancer Res. 2016 Dec 15; 22(24):6110-6117.
    View in: PubMed
    Score: 0.021
  53. Morphological Changes, Cadherin Switching, and Growth Suppression in Pancreatic Cancer by GALNT6 Knockdown. Neoplasia. 2016 05; 18(5):265-272.
    View in: PubMed
    Score: 0.021
  54. Oncogenic roles of TOPK and MELK, and effective growth suppression by small molecular inhibitors in kidney cancer cells. Oncotarget. 2016 Apr 05; 7(14):17652-64.
    View in: PubMed
    Score: 0.021
  55. Germline PARP4 mutations in patients with primary thyroid and breast cancers. Endocr Relat Cancer. 2016 Mar; 23(3):171-9.
    View in: PubMed
    Score: 0.021
  56. SUV420H1 enhances the phosphorylation and transcription of ERK1 in cancer cells. Oncotarget. 2015 Dec 22; 6(41):43162-71.
    View in: PubMed
    Score: 0.021
  57. Eradication of Large Solid Tumors by Gene Therapy with a T-Cell Receptor Targeting a Single Cancer-Specific Point Mutation. Clin Cancer Res. 2016 06 01; 22(11):2734-43.
    View in: PubMed
    Score: 0.021
  58. Regulation of iron homeostasis by the p53-ISCU pathway. Sci Rep. 2015 Nov 12; 5:16497.
    View in: PubMed
    Score: 0.021
  59. PRMT1 promotes mitosis of cancer cells through arginine methylation of INCENP. Oncotarget. 2015 Nov 03; 6(34):35173-82.
    View in: PubMed
    Score: 0.021
  60. SUV39H2 methylates and stabilizes LSD1 by inhibiting polyubiquitination in human cancer cells. Oncotarget. 2015 Jul 10; 6(19):16939-50.
    View in: PubMed
    Score: 0.020
  61. Pharmacoethnicity in Paclitaxel-Induced Sensory Peripheral Neuropathy. Clin Cancer Res. 2015 Oct 01; 21(19):4337-46.
    View in: PubMed
    Score: 0.020
  62. Dysregulation of AKT Pathway by SMYD2-Mediated Lysine Methylation on PTEN. Neoplasia. 2015 Apr; 17(4):367-73.
    View in: PubMed
    Score: 0.020
  63. Discovery of imidazo[1,2-b]pyridazine derivatives: selective and orally available Mps1 (TTK) kinase inhibitors exhibiting remarkable antiproliferative activity. J Med Chem. 2015 Feb 26; 58(4):1760-75.
    View in: PubMed
    Score: 0.020
  64. Preclinical efficacy of maternal embryonic leucine-zipper kinase (MELK) inhibition in acute myeloid leukemia. Oncotarget. 2014 Dec 15; 5(23):12371-82.
    View in: PubMed
    Score: 0.019
  65. Identification of novel epigenetically inactivated gene PAMR1 in breast carcinoma. Oncol Rep. 2015 Jan; 33(1):267-73.
    View in: PubMed
    Score: 0.019
  66. WHSC1 promotes oncogenesis through regulation of NIMA-related kinase-7 in squamous cell carcinoma of the head and neck. Mol Cancer Res. 2015 Feb; 13(2):293-304.
    View in: PubMed
    Score: 0.019
  67. VAV3 mediates resistance to breast cancer endocrine therapy. Breast Cancer Res. 2014 May 28; 16(3):R53.
    View in: PubMed
    Score: 0.019
  68. A rare polymorphic variant of NBS1 reduces DNA repair activity and elevates chromosomal instability. Cancer Res. 2014 Jul 15; 74(14):3707-15.
    View in: PubMed
    Score: 0.019
  69. Overexpression of cohesion establishment factor DSCC1 through E2F in colorectal cancer. PLoS One. 2014; 9(1):e85750.
    View in: PubMed
    Score: 0.018
  70. Identification of an HLA-A2-restricted epitope peptide derived from hypoxia-inducible protein 2 (HIG2). PLoS One. 2014; 9(1):e85267.
    View in: PubMed
    Score: 0.018
  71. The oncogenic polycomb histone methyltransferase EZH2 methylates lysine 120 on histone H2B and competes ubiquitination. Neoplasia. 2013 Nov; 15(11):1251-61.
    View in: PubMed
    Score: 0.018
  72. RASEF is a novel diagnostic biomarker and a therapeutic target for lung cancer. Mol Cancer Res. 2013 Aug; 11(8):937-51.
    View in: PubMed
    Score: 0.017
  73. Identification of a functional variant in the MICA promoter which regulates MICA expression and increases HCV-related hepatocellular carcinoma risk. PLoS One. 2013; 8(4):e61279.
    View in: PubMed
    Score: 0.017
  74. The transcription factor Sp3 regulates the expression of a metastasis-related marker of sarcoma, actin filament-associated protein 1-like 1 (AFAP1L1). PLoS One. 2013; 8(1):e49709.
    View in: PubMed
    Score: 0.017
  75. Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in breast cancer cells. Nat Commun. 2013; 4:2443.
    View in: PubMed
    Score: 0.017
  76. Integration of cell line and clinical trial genome-wide analyses supports a polygenic architecture of Paclitaxel-induced sensory peripheral neuropathy. Clin Cancer Res. 2013 Jan 15; 19(2):491-9.
    View in: PubMed
    Score: 0.017
  77. The histone methyltransferase Wolf-Hirschhorn syndrome candidate 1-like 1 (WHSC1L1) is involved in human carcinogenesis. Genes Chromosomes Cancer. 2013 Feb; 52(2):126-39.
    View in: PubMed
    Score: 0.017
  78. Identification of a novel oncogene, MMS22L, involved in lung and esophageal carcinogenesis. Int J Oncol. 2012 Oct; 41(4):1285-96.
    View in: PubMed
    Score: 0.016
  79. Histone lysine methyltransferase SETD8 promotes carcinogenesis by deregulating PCNA expression. Cancer Res. 2012 Jul 01; 72(13):3217-27.
    View in: PubMed
    Score: 0.016
  80. IRX4 at 5p15 suppresses prostate cancer growth through the interaction with vitamin D receptor, conferring prostate cancer susceptibility. Hum Mol Genet. 2012 May 01; 21(9):2076-85.
    View in: PubMed
    Score: 0.016
  81. Characterization of an Opa interacting protein 5 involved in lung and esophageal carcinogenesis. Cancer Sci. 2012 Mar; 103(3):577-86.
    View in: PubMed
    Score: 0.016
  82. In vivo therapeutic effect of CDH3/P-cadherin-targeting radioimmunotherapy. Cancer Immunol Immunother. 2012 Aug; 61(8):1211-20.
    View in: PubMed
    Score: 0.016
  83. Enhanced HSP70 lysine methylation promotes proliferation of cancer cells through activation of Aurora kinase B. Nat Commun. 2012; 3:1072.
    View in: PubMed
    Score: 0.016
  84. The JmjC domain-containing histone demethylase KDM3A is a positive regulator of the G1/S transition in cancer cells via transcriptional regulation of the HOXA1 gene. Int J Cancer. 2012 Aug 01; 131(3):E179-89.
    View in: PubMed
    Score: 0.016
  85. Chondrolectin is a novel diagnostic biomarker and a therapeutic target for lung cancer. Clin Cancer Res. 2011 Dec 15; 17(24):7712-22.
    View in: PubMed
    Score: 0.016
  86. Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway. Neoplasia. 2011 Oct; 13(10):887-98.
    View in: PubMed
    Score: 0.015
  87. The histone demethylase JMJD2B plays an essential role in human carcinogenesis through positive regulation of cyclin-dependent kinase 6. Cancer Prev Res (Phila). 2011 Dec; 4(12):2051-61.
    View in: PubMed
    Score: 0.015
  88. Identification of Epstein-Barr virus-induced gene 3 as a novel serum and tissue biomarker and a therapeutic target for lung cancer. Clin Cancer Res. 2011 Oct 01; 17(19):6272-86.
    View in: PubMed
    Score: 0.015
  89. Characterization of a cleavage stimulation factor, 3' pre-RNA, subunit 2, 64 kDa (CSTF2) as a therapeutic target for lung cancer. Clin Cancer Res. 2011 Sep 15; 17(18):5889-900.
    View in: PubMed
    Score: 0.015
  90. Enhanced expression of EHMT2 is involved in the proliferation of cancer cells through negative regulation of SIAH1. Neoplasia. 2011 Aug; 13(8):676-84.
    View in: PubMed
    Score: 0.015
  91. MRG-binding protein contributes to colorectal cancer development. Cancer Sci. 2011 Aug; 102(8):1486-92.
    View in: PubMed
    Score: 0.015
  92. Minichromosome Maintenance Protein 7 is a potential therapeutic target in human cancer and a novel prognostic marker of non-small cell lung cancer. Mol Cancer. 2011 May 28; 10:65.
    View in: PubMed
    Score: 0.015
  93. The human AIRE gene at chromosome 21q22 is a genetic determinant for the predisposition to rheumatoid arthritis in Japanese population. Hum Mol Genet. 2011 Jul 01; 20(13):2680-5.
    View in: PubMed
    Score: 0.015
  94. Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers. Int J Cancer. 2011 Feb 01; 128(3):574-86.
    View in: PubMed
    Score: 0.015
  95. Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers. Int J Cancer. 2011 Feb 01; 128(3):562-73.
    View in: PubMed
    Score: 0.015
  96. A functional single nucleotide polymorphism in mucin 1, at chromosome 1q22, determines susceptibility to diffuse-type gastric cancer. Gastroenterology. 2011 Mar; 140(3):892-902.
    View in: PubMed
    Score: 0.015
  97. Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility. Cancer Sci. 2011 Jan; 102(1):245-52.
    View in: PubMed
    Score: 0.014
  98. Leptin as a critical regulator of hepatocellular carcinoma development through modulation of human telomerase reverse transcriptase. BMC Cancer. 2010 Aug 19; 10:442.
    View in: PubMed
    Score: 0.014
  99. Cell-permeable peptide DEPDC1-ZNF224 interferes with transcriptional repression and oncogenicity in bladder cancer cells. Cancer Res. 2010 Jul 15; 70(14):5829-39.
    View in: PubMed
    Score: 0.014
  100. Phosphorylation and activation of cell division cycle associated 5 by mitogen-activated protein kinase play a crucial role in human lung carcinogenesis. Cancer Res. 2010 Jul 01; 70(13):5337-47.
    View in: PubMed
    Score: 0.014
  101. Wnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapy. Cancer Res. 2010 Jul 01; 70(13):5326-36.
    View in: PubMed
    Score: 0.014
  102. Crosstalk of EDA-A2/XEDAR in the p53 signaling pathway. Mol Cancer Res. 2010 Jun; 8(6):855-63.
    View in: PubMed
    Score: 0.014
  103. 5alphaDH-DOC (5alpha-dihydro-deoxycorticosterone) activates androgen receptor in castration-resistant prostate cancer. Cancer Sci. 2010 Aug; 101(8):1897-904.
    View in: PubMed
    Score: 0.014
  104. The forkhead box M1 transcription factor as a candidate of target for anti-cancer immunotherapy. Int J Cancer. 2010 May 01; 126(9):2153-63.
    View in: PubMed
    Score: 0.014
  105. Activation of an oncogenic TBC1D7 (TBC1 domain family, member 7) protein in pulmonary carcinogenesis. Genes Chromosomes Cancer. 2010 Apr; 49(4):353-67.
    View in: PubMed
    Score: 0.014
  106. Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway. Mol Cancer. 2010 Mar 13; 9:59.
    View in: PubMed
    Score: 0.014
  107. Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis. Cancer Res. 2010 Apr 01; 70(7):2759-69.
    View in: PubMed
    Score: 0.014
  108. Functional SNP of ARHGEF10 confers risk of atherothrombotic stroke. Hum Mol Genet. 2010 Mar 15; 19(6):1137-46.
    View in: PubMed
    Score: 0.014
  109. Activation of WD repeat and high-mobility group box DNA binding protein 1 in pulmonary and esophageal carcinogenesis. Clin Cancer Res. 2010 Jan 01; 16(1):226-39.
    View in: PubMed
    Score: 0.014
  110. Ubiquitination and downregulation of BRCA1 by ubiquitin-conjugating enzyme E2T overexpression in human breast cancer cells. Cancer Res. 2009 Nov 15; 69(22):8752-60.
    View in: PubMed
    Score: 0.014
  111. FCRL3, an autoimmune susceptibility gene, has inhibitory potential on B-cell receptor-mediated signaling. J Immunol. 2009 Nov 01; 183(9):5502-10.
    View in: PubMed
    Score: 0.014
  112. Critical roles of T-LAK cell-originated protein kinase in cytokinesis. Cancer Sci. 2010 Feb; 101(2):403-11.
    View in: PubMed
    Score: 0.014
  113. Serum REG4 level is a predictive biomarker for the response to preoperative chemoradiotherapy in patients with pancreatic cancer. Pancreas. 2009 Oct; 38(7):791-8.
    View in: PubMed
    Score: 0.013
  114. Overexpression of the potential kinase serine/ threonine/tyrosine kinase 1 (STYK 1) in castration-resistant prostate cancer. Cancer Sci. 2009 Nov; 100(11):2109-14.
    View in: PubMed
    Score: 0.013
  115. Activation of an estrogen/estrogen receptor signaling by BIG3 through its inhibitory effect on nuclear transport of PHB2/REA in breast cancer. Cancer Sci. 2009 Aug; 100(8):1468-78.
    View in: PubMed
    Score: 0.013
  116. Involvement of G-patch domain containing 2 overexpression in breast carcinogenesis. Cancer Sci. 2009 Aug; 100(8):1443-50.
    View in: PubMed
    Score: 0.013
  117. Radioimmunotherapy of solid tumors targeting a cell-surface protein, FZD10: therapeutic efficacy largely depends on radiosensitivity. Ann Nucl Med. 2009 Jul; 23(5):479-85.
    View in: PubMed
    Score: 0.013
  118. Orphan receptor tyrosine kinase ROR2 as a potential therapeutic target for osteosarcoma. Cancer Sci. 2009 Jul; 100(7):1227-33.
    View in: PubMed
    Score: 0.013
  119. Stanniocalcin 2 overexpression in castration-resistant prostate cancer and aggressive prostate cancer. Cancer Sci. 2009 May; 100(5):914-9.
    View in: PubMed
    Score: 0.013
  120. Involvement of epithelial cell transforming sequence-2 oncoantigen in lung and esophageal cancer progression. Clin Cancer Res. 2009 Jan 01; 15(1):256-66.
    View in: PubMed
    Score: 0.013
  121. Identification of C2orf18, termed ANT2BP (ANT2-binding protein), as one of the key molecules involved in pancreatic carcinogenesis. Cancer Sci. 2009 Mar; 100(3):457-64.
    View in: PubMed
    Score: 0.013
  122. HLA-A2-restricted CTL epitopes of a novel lung cancer-associated cancer testis antigen, cell division cycle associated 1, can induce tumor-reactive CTL. Int J Cancer. 2008 Dec 01; 123(11):2616-25.
    View in: PubMed
    Score: 0.013
  123. Non-transmissible Sendai virus encoding granulocyte macrophage colony-stimulating factor is a novel and potent vector system for producing autologous tumor vaccines. Cancer Sci. 2008 Nov; 99(11):2315-26.
    View in: PubMed
    Score: 0.013
  124. Over-expression of cysteine proteinase inhibitor cystatin 6 promotes pancreatic cancer growth. Cancer Sci. 2008 Aug; 99(8):1626-32.
    View in: PubMed
    Score: 0.012
  125. Activation of placenta-specific transcription factor distal-less homeobox 5 predicts clinical outcome in primary lung cancer patients. Clin Cancer Res. 2008 Apr 15; 14(8):2363-70.
    View in: PubMed
    Score: 0.012
  126. Radioimmunotherapy of human synovial sarcoma using a monoclonal antibody against FZD10. Cancer Sci. 2008 Feb; 99(2):432-40.
    View in: PubMed
    Score: 0.012
  127. Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas. Cancer Res. 2007 Dec 15; 67(24):11601-11.
    View in: PubMed
    Score: 0.012
  128. The lysine 831 of vascular endothelial growth factor receptor 1 is a novel target of methylation by SMYD3. Cancer Res. 2007 Nov 15; 67(22):10759-65.
    View in: PubMed
    Score: 0.012
  129. Novel 5 alpha-steroid reductase (SRD5A3, type-3) is overexpressed in hormone-refractory prostate cancer. Cancer Sci. 2008 Jan; 99(1):81-6.
    View in: PubMed
    Score: 0.012
  130. Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy. Cancer Sci. 2007 Nov; 98(11):1803-8.
    View in: PubMed
    Score: 0.012
  131. Involvement of kinesin family member 2C/mitotic centromere-associated kinesin overexpression in mammary carcinogenesis. Cancer Sci. 2008 Jan; 99(1):62-70.
    View in: PubMed
    Score: 0.012
  132. Gamma-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor pi subunit. Cancer Res. 2007 Oct 15; 67(20):9704-12.
    View in: PubMed
    Score: 0.012
  133. Fibroblast growth factor receptor 1 oncogene partner as a novel prognostic biomarker and therapeutic target for lung cancer. Cancer Sci. 2007 Dec; 98(12):1902-13.
    View in: PubMed
    Score: 0.012
  134. Activation of Holliday junction recognizing protein involved in the chromosomal stability and immortality of cancer cells. Cancer Res. 2007 Sep 15; 67(18):8544-53.
    View in: PubMed
    Score: 0.012
  135. Nucleobindin 1 controls the unfolded protein response by inhibiting ATF6 activation. J Biol Chem. 2007 Oct 05; 282(40):29264-72.
    View in: PubMed
    Score: 0.012
  136. Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas. Cancer Res. 2007 Mar 15; 67(6):2517-25.
    View in: PubMed
    Score: 0.011
  137. Functional SNP in an Sp1-binding site of AGTRL1 gene is associated with susceptibility to brain infarction. Hum Mol Genet. 2007 Mar 15; 16(6):630-9.
    View in: PubMed
    Score: 0.011
  138. Epigenetic inactivation of the deleted in lung and esophageal cancer 1 gene in nasopharyngeal carcinoma. Genes Chromosomes Cancer. 2007 Feb; 46(2):171-80.
    View in: PubMed
    Score: 0.011
  139. Increased expression of insulin-like growth factor-II messenger RNA-binding protein 1 is associated with tumor progression in patients with lung cancer. Clin Cancer Res. 2007 Jan 15; 13(2 Pt 1):434-42.
    View in: PubMed
    Score: 0.011
  140. Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma. Int J Oncol. 2006 Oct; 29(4):799-827.
    View in: PubMed
    Score: 0.011
  141. The neuromedin U-growth hormone secretagogue receptor 1b/neurotensin receptor 1 oncogenic signaling pathway as a therapeutic target for lung cancer. Cancer Res. 2006 Oct 01; 66(19):9408-19.
    View in: PubMed
    Score: 0.011
  142. PDZ-binding kinase/T-LAK cell-originated protein kinase, a putative cancer/testis antigen with an oncogenic activity in breast cancer. Cancer Res. 2006 Sep 15; 66(18):9186-95.
    View in: PubMed
    Score: 0.011
  143. EphA4 receptor, overexpressed in pancreatic ductal adenocarcinoma, promotes cancer cell growth. Cancer Sci. 2006 Nov; 97(11):1211-6.
    View in: PubMed
    Score: 0.011
  144. Identification of TOMM34, which shows elevated expression in the majority of human colon cancers, as a novel drug target. Int J Oncol. 2006 Aug; 29(2):381-6.
    View in: PubMed
    Score: 0.011
  145. Identification of p53-46F as a super p53 with an enhanced ability to induce p53-dependent apoptosis. Cancer Sci. 2006 Jul; 97(7):633-41.
    View in: PubMed
    Score: 0.011
  146. Serial analysis of gene expression in progressing and regressing mouse tumors implicates the involvement of RANTES and TARC in antitumor immune responses. Mol Ther. 2006 Oct; 14(4):599-606.
    View in: PubMed
    Score: 0.011
  147. Identification of secernin 1 as a novel immunotherapy target for gastric cancer using the expression profiles of cDNA microarray. Cancer Sci. 2006 May; 97(5):411-9.
    View in: PubMed
    Score: 0.011
  148. Expression of novel molecules, MICAL2-PV (MICAL2 prostate cancer variants), increases with high Gleason score and prostate cancer progression. Clin Cancer Res. 2006 May 01; 12(9):2767-73.
    View in: PubMed
    Score: 0.011
  149. Overexpression of peptidyl-prolyl isomerase-like 1 is associated with the growth of colon cancer cells. Clin Cancer Res. 2006 Jan 01; 12(1):70-6.
    View in: PubMed
    Score: 0.010
  150. Identification of SP5 as a downstream gene of the beta-catenin/Tcf pathway and its enhanced expression in human colon cancer. Int J Oncol. 2005 Dec; 27(6):1483-7.
    View in: PubMed
    Score: 0.010
  151. Up-regulation of PSF2, a member of the GINS multiprotein complex, in intrahepatic cholangiocarcinoma. Oncol Rep. 2005 Sep; 14(3):701-6.
    View in: PubMed
    Score: 0.010
  152. Identification of pigment epithelium-derived factor as a direct target of the p53 family member genes. Oncogene. 2005 Jul 28; 24(32):5131-6.
    View in: PubMed
    Score: 0.010
  153. Aberrant laminin beta3 isoforms downstream of EWS-ETS fusion genes in Ewing family tumors. Cancer Biol Ther. 2005 Apr; 4(4):449-55.
    View in: PubMed
    Score: 0.010
  154. Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy. Clin Cancer Res. 2005 Apr 01; 11(7):2702-12.
    View in: PubMed
    Score: 0.010
  155. WDRPUH, a novel WD-repeat-containing protein, is highly expressed in human hepatocellular carcinoma and involved in cell proliferation. Neoplasia. 2005 Apr; 7(4):348-55.
    View in: PubMed
    Score: 0.010
  156. Proliferation potential-related protein, an ideal esophageal cancer antigen for immunotherapy, identified using complementary DNA microarray analysis. Clin Cancer Res. 2004 Oct 01; 10(19):6437-48.
    View in: PubMed
    Score: 0.010
  157. Isolation of LEM domain-containing 1, a novel testis-specific gene expressed in colorectal cancers. Oncol Rep. 2004 Aug; 12(2):275-80.
    View in: PubMed
    Score: 0.009
  158. Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses. J Hum Genet. 2004; 49(3):134-140.
    View in: PubMed
    Score: 0.009
  159. Genes associated with liver metastasis of colon cancer, identified by genome-wide cDNA microarray. Int J Oncol. 2004 Feb; 24(2):305-12.
    View in: PubMed
    Score: 0.009
  160. Adenovirus-mediated p53AIP1 gene transfer as a new strategy for treatment of p53-resistant tumors. Cancer Sci. 2004 Jan; 95(1):91-7.
    View in: PubMed
    Score: 0.009
  161. Identification of BMP and activin membrane-bound inhibitor (BAMBI), an inhibitor of transforming growth factor-beta signaling, as a target of the beta-catenin pathway in colorectal tumor cells. J Biol Chem. 2004 Feb 20; 279(8):6840-6.
    View in: PubMed
    Score: 0.009
  162. Identification of candidate predictive markers of anticancer drug sensitivity using a panel of human cancer cell lines. Cancer Sci. 2003 Dec; 94(12):1074-82.
    View in: PubMed
    Score: 0.009
  163. Identification of the interleukin 4 receptor alpha gene as a direct target for p73. Cancer Res. 2003 Dec 01; 63(23):8145-52.
    View in: PubMed
    Score: 0.009
  164. Genome-wide analysis of gene-expression profiles in chronic myeloid leukemia cells using a cDNA microarray. Int J Oncol. 2003 Sep; 23(3):681-91.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.